Systemic metabolic crosstalk as driver of cancer cachexia
Trends in Endocrinology & Metabolism · 2025-09 · 36 (9) · 815-826
DOI: 10.1016/j.tem.2024.12.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2025-09. Verfasst von Elisabeth Wyart und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Torino, 10126 Torino, Italy. …. Hauptthemen laut MEDLINE: Cachexia, Neoplasms, Energy Metabolism. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: Ministero dell'Università e della Ricerca, Fondazione AIRC per la ricerca sul cancro ETS, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Cachexia is a complex metabolic disorder characterized by negative energy balance due to increased consumption and lowered intake, leading to progressive tissue wasting and inefficient energy distribution. Once considered as passive bystander, metabolism is now acknowledged as a regulator of biological functions and disease progression. This shift in perspective mirrors the evolving understanding of cachexia itself, no longer viewed merely as a secondary consequence of cancer but as an active process. However, metabolic dysregulations in cachexia are currently studied in an organ-specific manner, failing to be fully integrated into a comprehensive framework that explains their functional roles in disease progression. Thus, in this review, we aim to provide a general overview of the various metabolic alterations with a potential systemic impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Torino, 10126 Torino, Italy. Electronic address: elisabeth.wyart@unito.it.
- San Luigi Gonzaga Hospital, Orbassano, Italy; Department of Clinical and Biological Science, University of Torino, Orbassano, Italy.
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
- Department of Clinical and Biological Science, University of Torino, Orbassano, Italy.
- Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Torino, 10126 Torino, Italy. Electronic address: paolo.porporato@unito.it.
Förderung
- Ministero dell'Università e della Ricerca
- Fondazione AIRC per la ricerca sul cancro ETS
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Wyart, E., Carrà, G., Angelino, E., Penna, F., & Porporato, P. E. (2025). Systemic metabolic crosstalk as driver of cancer cachexia. Trends in Endocrinology & Metabolism, 36(9), 815-826. https://doi.org/10.1016/j.tem.2024.12.005
Vancouver
Wyart E, Carrà G, Angelino E, Penna F, Porporato PE. Systemic metabolic crosstalk as driver of cancer cachexia. Trends in Endocrinology & Metabolism. 2025;36(9):815-826. doi:10.1016/j.tem.2024.12.005
BibTeX
@article{Wyart2025,
author = {Wyart, Elisabeth and Carrà, Giovanna and Angelino, Elia and Penna, Fabio and Porporato, Paolo E},
title = {Systemic metabolic crosstalk as driver of cancer cachexia},
journal = {Trends in Endocrinology & Metabolism},
year = {2025},
volume = {36},
number = {9},
pages = {815--826},
doi = {10.1016/j.tem.2024.12.005}
}
EUVIMED